Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
13. March 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 9314
Articles 1 - 20 / 186272
Stated Preferences for Systemic Treatments for Prostate Cancer: A Targeted Review of the Discrete-Choice Experiment Literature.
Patient
Agarwal N, Hauber B, Hong A, Coulter J, Russell D, Ryan M, Darnell S, Watson V, Collins SP.
PMID: 41817839 [PubMed - as supplied by publisher]
The prostate cancer electronic health (eHealth) literacy instrument: a tool for eHealth design and patient communication.
BJU Int
Jackson SR, Yu P, Sowter S, Occhipinti S, Chambers S, Leslie S, Patel MI.
PMID: 41817041 [PubMed - as supplied by publisher]
Evaluation of the relationship between pan-immune inflammation value and prognostic factors in germ-cell testicular cancer: analysis of stage, lymph node involvement, and metastasis.
Turk J Med Sci
Dinçer E, Özkaptan O, Çanakçi C, Ipek OM, Co, Sevinç AH.
PMID: 41816726 [PubMed - indexed for MEDLINE]
Liver metastases in advanced urothelial carcinoma (ARON-2): do pembrolizumab and avelumab make a difference in a poor-prognosis scenario?
Front Immunol
Cerbone L, Roviello G, Calabrò F, Taha T, Grande E, Binz K, Kanesvaran R, Pirstuk A, Fiala O, Molina-Cerrillo J, Alonso-Gordoa T, Rizzo A, Pichler R, Myint ZW, Poprach A, Facchini G, Bohuslav M, Studentova H, Morelli F, Buchler T, Mennitto A, Tural D, Formisano L, Orejana I, Catalano M, Buti S, Monteiro FSM, Soares A, Gupta S, Massari F, Santoni M.
PMID: 41816343 [PubMed - indexed for MEDLINE]
bp-VI-RADS combined with normalized apparent diffusion coefficient enhances diagnostic efficacy for muscle-invasive bladder cancer.
Quant Imaging Med Surg
Hao Z, Zhu L, Ding J, Jin Q, Du X, Wang X, Shi Y, Guo H, Li D, Yang R.
PMID: 41816041 [PubMed]
Diagnosis of bladder diverticular tumor by transrectal biplanar ultrasonography: a case report.
Int J Surg Case Rep
You Y, Li L, Liu X, Xing J, Fan X.
PMID: 41815992 [PubMed]
Defining the learning curve for thulium Laser en bloc resection of bladder tumors: a single-surgeon retrospective cohort study.
Front Surg
Qing X, Wu X, Gao W.
PMID: 41815783 [PubMed]
Risk of second primary malignancies in prostate cancer patients: A Surveillance, Epidemiology, and End Results population-based study.
Asian J Urol
Shou J, Wo Q.
PMID: 41815370 [PubMed]
Recurrence and prevention strategies for non-muscle-invasive bladder cancer: A comprehensive review.
Asian J Urol
Liu W, Xiao J, Zou J, He Z.
PMID: 41815366 [PubMed]
Neoadjuvant androgen deprivation therapy with bicalutamide compared to hormonal agents in treating high-risk prostate cancer: a real-world cohort study.
Transl Cancer Res
Liu J, Cui Y, Tang X, Ma J, Du P.
PMID: 41815147 [PubMed]
Allergy to cabazitaxel: Cross-reactivity between taxanes.
Allergol Immunopathol (Madr)
Fernández-Paredes PC, Guerrero MN, de la Puente EP, Lopez-Sanchez JD.
PMID: 41814617 [PubMed - indexed for MEDLINE]
Vitamin D and Bladder Cancer Risk: An Umbrella Review and Second Order Meta-Analysis.
Cancer Med
Mancin S, Ferrara G, Palomares SM, Matteucci S, Santagostino AM, Ferrari G, Parozzi M, Petrelli F, Hurle R, Sguanci M, Cangelosi G.
PMID: 41814462 [PubMed - indexed for MEDLINE]
Ultrasound-assisted diagnosis and ultrasound-guided radiofrequency ablation of renal cell carcinoma in a patient with autosomal dominant polycystic kidney disease: a case report with two-year follow-up.
BMC Nephrol
Yu X, Liu R, Sun Z, Wang L, Ma J, Wang S, Liu X, Zhang B.
PMID: 41814207 [PubMed - as supplied by publisher]
Management of Lower Urinary Tract Symptoms in Patients on Active Surveillance for Prostate Cancer.
Curr Urol Rep
Kapoor J, Cheung F.
PMID: 41813844 [PubMed - in process]
Pilot study of dual-arm absolute quantification of miR-130a and miR-365a in plasma and urine reveals 3p/5p strand-ratio shifts in prostate cancer.
Sci Rep
Romanescu M, Bendelic AI, Ciordas PD, Dema V, Bardan TR, Cumpanas AA, Chis AR, Marian C, Sirbu LO.
PMID: 41813789 [PubMed - as supplied by publisher]
Incomplete thermal ablation accelerates local and systemic tumor progression in an immunocompetent prostate cancer model.
Int J Hyperthermia
Kader A, Ranner-Hafferl MHH, Polz AL, Mülleder M, Farztdinov V, Fendler A, Collettini F, Auer TA.
PMID: 41813588 [PubMed - indexed for MEDLINE]
Targeted and Perilesional or Systematic Biopsies in Prostate Cancer: The TARGET Clinical Trial Protocol.
Eur Urol Oncol
Baboudjian M, Sordelli F, Patard JJ, Moussi B, Graffeille V, Basset V, Legraverend D, Bastide C, Daniel L, Beauval JB, Rouprêt M, Robert G, Ploussard G.
PMID: 41813528 [PubMed - as supplied by publisher]
From bench to bedside: translating the histone deacetylase inhibitors into prostate cancer therapies.
Clin Chim Acta
Rocha SM, Brás MB, Pereira BJ, Maia CJ.
PMID: 41812786 [PubMed - as supplied by publisher]
Reirradiation Options for Previously Irradiated Prostate Cancer: Is It Feasible to Randomise Between Treatment With Stereotactic Body Radiotherapy (SBRT) Versus High-Dose-Rate Brachytherapy?
Clin Oncol (R Coll Radiol)
Zhong J, Slevin F, Brown S, Serra M, Bownes P, Thompson C, Reed R, Reeves K, Dubec M, Eccles C, Chuter R, Tsang YM, Taylor NJ, West CML, Buckley D, Alonzi R, Scarsbrook A, Choudhury A, Hoskin P, Henry AM.
PMID: 41812301 [PubMed - as supplied by publisher]
European Study of Prostate Cancer Screening - 23-Year Follow-up.
N Engl J Med
PMID: 41812212 [PubMed - in process]
Articles 1 - 20 / 186272
Page 1 of 9314
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy